Structural Formula (Tyzavan Vancomycin Injection 1)
Tyzavan Injection, Solution
Product Images NDC 0143-9472
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 25 technical images submitted to the FDA as part of the official labeling for Tyzavan (NDC 0143-9472). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
1g 200ml Bag Label (Tyzavan Vancomycin Injection 10)
This text is a product label for TYZAVAN® (vancomycin injection, USP), a medication provided in a single-dose flexible bag for intravenous infusion. It contains important information such as dosage instructions, cautions, storage conditions, composition details, and manufacturer information. The medication is intended for Rx use only and should be infused over at least 60 minutes. Additional details are provided on the proper handling, usage, and storage requirements of the product.*
1g 200ml Ow (Tyzavan Vancomycin Injection 11)
This is a description of TYZAVAN, a vancomycin injection in a single-dose flexible bag for intravenous infusion only. The medication is in a new formulation ready to use and should be infused over at least 60 minutes. It is important not to add any supplementary medication or additives. The product should be stored between 15°C to 25°C and used within 28 days of removal from the aluminum overpouch. Each 100 mL contains vancomycin hydrochloride, N-acetyl-D-alanine, and L-lysine hydrochloride. The pH may have been adjusted with hydrochloric acid and/or sodium hydroxide. This medication is manufactured for Hikma Pharmaceuticals USA, Inc. and made in Switzerland.*
1g 200ml Ctn06 (Tyzavan Vancomycin Injection 12)
1g 200ml Ctn12 (Tyzavan Vancomycin Injection 13)
1.25g Bag Label (Tyzavan Vancomycin Injection 14)
This is a description for a medication called TYZAVAN® (vancomycin injection, USP). It is a sterile and nonpyrogenic solution for intravenous infusion only. Each 100 mL contains vancomycin hydrochloride equivalent to 500 mg vancomycin, N-acetyl-D-alanine, and Lysine hydrochloride in water for injection. The dosage information is available in the prescribing information, and it should be infused over at least 60 minutes. Caution is advised against adding supplementary medications or additives, and any unused portion should be discarded. It should be stored at 15°C to 25°C and used within 28 days of removal from the aluminum overpouch. This medication is distributed by Hikma Pharmaceuticals USA, Inc. and manufactured in Switzerland.*
1.25 250ml Ow (Tyzavan Vancomycin Injection 15)
This text is a prescription label for Vancomycin injection, USP, in a single-dose flexible bag. It provides information on the dosage, administration, and storage of the medication. The bag contains 1.25 g of Vancomycin in 250 mL. The label warns not to add supplementary medication, discard unused portions, and use within 28 days. The pH may have been adjusted with hydrochloric acid or sodium hydroxide. The medication is manufactured for Hikma Pharmaceuticals USA, Inc.Overall, it gives important details for the safe and effective use of the product.*
1.25 250ml Ctn (Tyzavan Vancomycin Injection 16)
1.5g 300ml Bag (Tyzavan Vancomycin Injection 17)
This is a medication label for TYZAVAN® (vancomycin injection, USP) provided in a single-dose flexible bag for intravenous infusion. It contains 1.5 g of vancomycin in 300 mL solution. The caution advises against adding supplementary medications or additives and to discard any unused portion. The storage temperature range is specified, and it should be used within 28 days after removal from the aluminum overpouch. The detailed composition includes vancomycin hydrochloride, N-acetylD-alanine, and L-lysine hydrochloride. The medication is manufactured in Switzerland and distributed by Hikma Pharmaceuticals USA, Inc.*
1.5g 300ml Ow (Tyzavan Vancomycin Injection 18)
This text contains information about Vancomycin injection, USP, in a 1.5g/300mL concentration. It is a single-dose flexible bag for sterile, nonpyrogenic use. The medication should be infused over at least 60 minutes and should only be used for intravenous infusion. It provides cautions against adding supplementary medications or additives and advises discarding any unused portion. The storage conditions, ingredients, and manufacturer details are also provided in the text.*
1.5g 300ml Ctn (Tyzavan Vancomycin Injection 19)
Hikma Logo (Tyzavan Vancomycin Injection 2)
1.75 350ml Bag (Tyzavan Vancomycin Injection 20)
This is a description of TYZAVAN®, a vancomycin injection used for intravenous infusion only. It comes in a 1.75g/350mL single-dose flexible bag and should be infused over at least 60 minutes. Cautions include not adding supplementary medications or additives, discarding any unused portion, and storing between 15°C to 25°C. The product contains vancomycin hydrochloride, N-acetyl-D-slanine, and L-iysine hydrochloride. It is manufactured by Hikma Pharmaceuticals USA, Inc., and the packaging indicates it is made in Switzerland.*
1.75g 350ml Ow (Tyzavan Vancomycin Injection 21)
This is a description of a medication called Vancomycin Injection, USP, indicated for intravenous infusion only. The single-dose flexible bag is sterile, non-pyrogenic, and contains 1.75g of vancomycin in 350mL (5 mg/mL). It is a new formula that is ready to use and should be infused over at least 60 minutes. The caution states not to add supplementary medication or additives, and any unused portion should be discarded. The medication must be stored at 15°C to 25°C and used within 28 days of removal from the original package. The composition includes vancomycin hydrochloride, N-acetyl-D-alanine, and lysine hydrochloride. The pH may have been adjusted with hydrochloric acid and/or sodium hydroxide. The medication is manufactured for Hikma Pharmaceuticals USA, Inc. and made in Switzerland.*
1.75 350ml Ctn (Tyzavan Vancomycin Injection 22)
2g 400ml Bag (Tyzavan Vancomycin Injection 23)
This text contains information about a medication called TYZAVAN, which is a vancomycin injection, USP. It is provided in a single-dose flexible bag sterlle, nonpyrogenic form, with a concentration of 2g/400 mL (5 mg/ml). The dosage should be followed as per the prescribing information, and it is for intravenous infusion only, to be infused over at least 60 minutes. Cautions include not adding supplementary medication or additives, and unused portions should be discarded. The storage conditions are specified as between 15°C to 25°C (59°F to 77°F) in the original package, and it should be used within 28 days of removal from the aluminum overpouch. The composition includes vancomycin hydrochloride, N-acetyl-D-alanine, and L-lysine hydrochloride. The medication is manufactured for Hikma Pharmaceuticals USA, Inc., and it has a manufacturing date of March 2025.*
2g 400ml Ow (Tyzavan Vancomycin Injection 24)
This is a description of a medication called vancomycin injection, USP. It is a 2 g/400 mL solution in a single-dose flexible bag that is sterile and non-pyrogenic. The new formulation is ready to use and is intended for intravenous infusion only, to be administered over at least 60 minutes. It is important not to add supplementary medications or additives, and any unused portion should be discarded. The product should be stored between 15°C to 25°C and used within 28 days of removal from the original package. Each 100 mL contains a specific concentration of vancomycin hydrochloride, N-acetyl-D-alanine, and Lysine hydrochloride in water for injection. The pH of the solution may have been adjusted using hydrochloric acid and/or sodium hydroxide. This medication is manufactured for Hikma Pharmaceuticals USA, Inc., with additional information regarding manufacturing location and revision date.*
2g 400ml Ctn (Tyzavan Vancomycin Injection 25)
Bag (Tyzavan Vancomycin Injection 3)
This is a product label for Vancomycin injection, USP. It provides information on dosage, administration (intravenous infusion only over 60 minutes), storage conditions (15°C to 25°C), caution on not adding supplementary medication, and expiration date of 28 days after removal from the aluminum overpouch. The content includes details on ingredients and formulation, such as Vancomycin hydrochloride, N-acetyl-D-alanine, and Lysine hydrochloride. The product is manufactured for Hikma Pharmaceuticals USA, Inc., based in Berkeley Heights, NJ. The text also mentions the lot number, expiry date, and RxOnly designation.*
500mg Ow (Tyzavan Vancomycin Injection 4)
This text is about a medication called TYZAVAN® (vancomycin injection, USP) with a strength of "500 mg/ 100 mL (5 mg/mL)" provided in a single-dose flexible bag. The medication is for intravenous infusion only and should be infused over 60 minutes. It also provides cautions regarding supplementary medications and storage instructions between 15-25°C. The expiration date mentioned in the text is March 2025.*
Ctn (Tyzavan Vancomycin Injection 5)
The text appears to be a detailed description of a medical product - TYZAVAN® (vancomycin injection, USP) in a flexible bag form. It provides information on the dosage, storage instructions, and usage guidelines. The product contains 500 mg/100 mL of vancomycin and is intended for intravenous administration. It is mentioned to store between 5°C to 25°C and discard any unused portion. The packaging contains single-dose flexible bags. This product seems to be for medical use and requires a prescription for administration.*
500mg Ctn 12 (Tyzavan Vancomycin Injection 6)
750mg Bag Label (Tyzavan Vancomycin Injection 7)
This text provides information about TYZAVAN, a vancomycin injection in a single-dose flexible bag for intravenous infusion only. The dosage, storage instructions, caution against adding supplementary medication, and details on its components are included. It mentions the manufacturer as Hikma Pharmaceuticals USA, Inc., and the product is made in Switzerland. It also provides the expiration date as March 2025.*
750mg Ow (Tyzavan Vancomycin Injection 8)
This text provides detailed information about TYZAVAN® (vancomycin injection, USP) in a single-dose flexible bag. The prescription drug is ready to use and must be used for intravenous infusion only over at least 60 minutes. The cautions include not adding supplementary medications or additives and discarding any unused portion. Proper storage conditions are specified within the temperature range of 15°C to 25°C. The formulation should be used within 28 days of removal from the aluminum overpouch. Details of the ingredients and pH adjustments are also included. The drug is manufactured for Hikma Pharmaceuticals USA, Inc., and made in Switzerland. This product seems to be suitable for healthcare professionals who require a ready-to-use vancomycin injection for IV infusion.*
750mg-150ml Ctn06 (Tyzavan Vancomycin Injection 9)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
